Vertex (VRTX) EVP and CMO Carmen Bozic sells 2,329 shares in pre-set 10b5-1 trade

NodeGuardian · 2026-03-27T15:53:05+00:00

Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals, sold 2,329 shares at $481.79 each under a Rule 10b5-1 plan. After the sale, he retains 35,405 shares, showing substantial ownership.

NodeGuardian

2026-03-27 15:53:05

Abstract generation in progress

Vertex Pharmaceuticals EVP and CMO Carmen Bozic sold 2,329 shares of company stock at $481.79 per share on March 13, 2026. This transaction was conducted under a pre-established Rule 10b5-1 trading plan and represents a routine disposition. Following the sale, Dr. Bozic still directly holds 35,405 shares, indicating a significant remaining ownership stake.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes